Menu
Back to Journals » Clinical Ophthalmology » Volume 10
A new endocapsular open ring for prevention of anterior and posterior capsule opacification
Authors Pallikaris IG, Stojanovic NR, Ginis HS
Received 19 February 2016
Accepted for publication 19 July 2016
Published 3 November 2016 Volume 2016:10 Pages 2205—2212
DOI https://doi.org/10.2147/OPTH.S106770
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 2
Editor who approved publication: Dr Scott Fraser
Ioannis G Pallikaris, Nela R Stojanovic, Harilaos S Ginis
Institute of Vision and Optics, Department of Medicine, University of Crete, Heraklion, Crete, Greece
Purpose: The aim of this study is to demonstrate the functionality of a new design of a thick endocapsular open ring for prevention of anterior capsule opacification (ACO) and posterior capsule opacification (PCO).
Setting: The Institute of Vision and Optics, University of Crete and University Hospital of Heraklion, Crete, Greece.
Design: Prospective, interventional pilot study.
Methods: Fifteen patients (17 eyes) underwent cataract surgery with phacoemulsification. During surgery, a thick endocapsular open ring (peripheral capsule reconstructor) was inserted into the capsular bag, prior to intraocular lens (IOL) implantation. Six different models of IOL were implanted. Postoperatively, the degree of ACO and PCO was evaluated and described as none, mild, moderate, or severe.
Results: The mean follow-up period was 30±8.06 months (range: 12–36 months). At the last follow-up, mild PCO was observed in only three eyes and mild ACO in three patients. The centration of IOLs was good in all but one eye, which had a tilted IOL.
Conclusion: The results of this pilot study suggest that the implantation of a new design of thick endocapsular open ring is feasible and may contribute to the prevention of PCO and ACO after cataract surgery.
Keywords: intraocular implant, cataract, phacoemulsification, silicone
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.